DOVIPEGLEUKIN
UNII R55C9TF7AB

Substance Identification & Data

This profile provides standardized clinical and technical data for Dovipegleukin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R55C9TF7AB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3076365-91-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

R55C9TF7AB

CAS Registry Number

3076365-91-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DOVIPEGLEUKIN

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

14175

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Dovipegleukin

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Dovipegleukin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Dovipegleukin

Common Names & Synonyms

2-133-Interleukin 2 [125-serine] (recombinant human SAR444336), 16-[N6-[[2-[8,9-dihydro-8-[4-[(2-hydroxyethyl)amino]-1,4-dioxobutyl]-1H(or 3H)-benzo[c]-1,2,3-triazolo[4,5-e][1]benzazocin-1(or 3)-yl]ethoxy]carbonyl]-L-lysine], 16-ether with α-methyl-ω-hydroxypoly(oxy-1,2-ethanediyl (50000 Da)

dovipegleukin [INN]

human interleukin 2 (IL2, IL-2, T-cell growth factor (TCGF); Uniprot: P60568) fragment (2-133 in the current sequence), variant (H16>N6 (2-azidoethoxy)-carbonyl-L-lysine, C125>S) to allow for a site-specific pegylation at position 16 with a {2-[8-(4-{[α-methylpoly(oxyethylene)-ω-yl]amino}-4-oxobutanoyl)-8,9-dihydro-1H (or 3H)-dibenzo[b,f][1,2,3]triazolo[4,5-d]azocin-1 (or 3)-yl]ethoxy}carbonyl group, produced in Escherichia coli strain BL21(DE3), not glycosylated

External Clinical & Regulatory Resources

Previous UNIIR555WMX5UK

Next UNIIR55SU7FW27